KARL STORZ Enters Merger Agreement with Asensus Surgical

In The News
June 7, 2024

Ropes & Gray advised KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG, a global medical technology company, in its entry into a merger agreement with Asensus Surgical, Inc. that will create a leading surgical robotics division within KARL STORZ. The transaction was announced in a June 7 press release.

The transaction is anticipated to close during the third quarter of 2024, pending approval from the Asensus stockholders. Upon completion of the transaction, Asensus Surgical will become a subsidiary of KARL STORZ Endoscopy-America and will no longer be publicly listed or traded on the NYSE American Exchange.

KARL STORZ, founded in 1945 in Tuttlingen, Germany, is a leader in the world of endoscopy with 13,000 products for human and veterinary medicine. Preliminary sales in the 2023 financial year amounted to 2.17 billion euros.

The team included mergers & acquisitions partner Emily Oldshue and associate Debbie Wang, life sciences regulatory & compliance partner Josh Oyster, employment partner Renata Ferrari, tax partner Alyssa Kollmeyer, finance partner Dan Coyne, business restructuring partner Cristine Pirro Schwarzman, antitrust partner Ruchit Patel, and IP transactions partner Regina Sam Penti and counsel Georgina Jones Suzuki.